Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

942
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
942
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Apoptosis-inducing effect and structural basis of Polygonatum cyrtonema lectin and chemical modification properties on its mannose-binding sites.

BMB reports·2008
Same author

The catalytic intermediate stabilized by a "down" active site loop for diaminopimelate decarboxylase from Helicobacter pylori. Enzymatic characterization with crystal structure analysis.

The Journal of biological chemistry·2008
Same author

Monitoring prostate thermal therapy with diffusion-weighted MRI.

Magnetic resonance in medicine·2008
Same author

Removal of ammonia nitrogen in wastewater by microwave radiation.

Journal of hazardous materials·2008
Same author

[Three-dimensional anatomical position of rotatory center in cervical rotatory and local manipulation].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2008
Same author

Dysregulation of CREB binding protein triggers thrombin-induced proliferation of vascular smooth muscle cells.

Molecular and cellular biochemistry·2008

相关实验视频

Updated: Jan 8, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

MOCT:用于协同药物组合预测的多类斜树算法.

Zhikai Lin, Jing Chen, Lianlian Wu

    IEEE transactions on computational biology and bioinformatics
    |December 18, 2025
    PubMed
    概括

    这项研究引入了一种基于集群的曲决策树 (MOCT) 算法,用于药物组合预测. MOCT有效地处理了阶级不平衡,并提高了用于生物和医学应用的模型解释性.

    科学领域:

    • 计算生物学是一种计算生物学.
    • 机器学习是机器学习.
    • 药理学 药理学是指药理学的学科.

    背景情况:

    • 机器学习模型越来越多地用于药物组合预测.
    • 阶级不平衡和缺乏可解释性是当前预测模型的重大挑战.
    • 现有的方法很难在复杂的生物数据集中有效解决这些问题.

    研究的目的:

    • 提出一个新的基于集群的斜决策树 (MOCT) 算法.
    • 从多类数据集中提取可解释的知识,特别是用于药物组合预测.
    • 解决传统方法在处理类不平衡和确保模型可解释性方面的局限性.

    主要方法:

    • 开发了一个基于集群的斜决策树 (MOCT) 算法.
    • 实施了分层聚类方法,按类别分组样本.
    • 为数据分割和节点创建生成特征子空间,优化可解释性和简洁性.
    • MOCT每层只生长一个非叶节点,确保了紧的树结构.

    主要成果:

    • 与其他方法相比,MOCT算法在药物组合预测任务中表现优越.
    • 提出的方法有效地处理了与生物数据集固有的阶级不平衡问题.
    • 来自三个细胞系的实验结果显示,模型的解释性得到了增强,这对于生物学和医学专家来说至关重要.

    更多相关视频

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    相关实验视频

    Last Updated: Jan 8, 2026

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    结论:

    • MOCT算法为药物组合预测提供了强大的解决方案,特别是在有阶级失衡的场景中.
    • MOCT的可解释性促进了对临床应用的预测模型的更好理解和信任.
    • 这种方法通过提供可解释和准确的预测,促进了机器学习在精密医学中的应用.